Cancer Trials CareLink for Patient Self Reports

描述(由申请者提供)：我们建议癌症试验CareLink，一个 基于互联网的系统收集研究-质量，自我报告的质量 直接来自患者的生活、支持性护理和满意度结果 他们的家。患者自我报告的数据对于以下方面至关重要 在临床试验和日常癌症护理中比较治疗方法。 基于互联网的数据收集为改善 与替代方案相比，数据捕获的质量、及时性和成本 方法：研究方法。癌症试验CareLink将患者与他们的癌症直接联系起来 试验站点通过专用、安全的互联网渠道实现双向、 患者和他们的提供者之间的多媒体交流。患者会 拥有对所需内容和功能的广泛访问权限，以帮助他们 每天的癌症护理。使用以患者为中心的关怀情景门户环境 对于数据收集，患者将被激励、授权和支持，从而 他们可能更容易和更愿意为以下项目提供研究质量的自我报告 临床试验。好处包括提高对试验的满意度 参与，更轻松的自我报告，改善对试验方案的遵守， 和更低的数据收集成本。我们的第一阶段研究将证明 具有工作原型的可行性，患者可以并将使用该原型来 从他们的家中向临床医生/研究人员提供自我报告的数据，网址为 当地的一个试验点。 建议的商业应用： 癌症试验CareLink是包括医院在内的癌症试验地点所需要的，也将对其有价值 大学研究中心和癌症中心。这些机构正在投资更多 收集和管理数据并与患者保持沟通的高效手段 人口。制药公司和合同研究机构可以使用癌症 试验CareLink加强从试验中的患者收集临床和结果数据 在试验期间和一段时间内监测药物安全性。

DESCRIPTION (provided by applicant): We propose Cancer Trials CareLink, an Internet-based system to gather research-quality, self-reported quality of life, supportive care, and satisfaction outcomes directly from patients in their homes. Patient self-reported data are of paramount importance for comparing treatments in clinical trials and in daily cancer care. Internet-based data collection offers significant advantages for improving the quality, timeliness, and cost of data capture, compared with alternative methods. Cancer Trials CareLink will link patients directly to their cancer trials site through a dedicated, secure Internet channel enabling two-way, multi-media communication between patients and their providers. Patients will have broad access to needed content and functionality to help them in their daily cancer care. Using a patient-centric, care contextual portal environment for data gathering, patients will be motivated, empowered, and supported so they may more easily and willingly provide research-quality self-reports for clinical trials. Benefits will include improved satisfaction with trials participation, easier self reporting, improved compliance with trial protocols, and lower data collection costs. Our Phase I research will demonstrate feasibility by having a working prototype that patients can and will use to provide self-reported data from their homes to their clinicians/researchers at a local trial site. PROPOSED COMMERCIAL APPLICATION: Cancer Trials CareLink is needed by and will be of value to cancer trial sites including hospitals university research centers and cancer centers. These institutions are investing in more efficient means to collect and manage data and to maintain communication with their patient populations. Pharmaceutical companies and contract research organizations can use Cancer Trials CareLink to enhance clinical and outcomes data collection from patients in trials and to monitor drug safety during trials and over time.